SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lupus injection enters first human tests
Disease control Not yet recruitingThis early-stage study tests a new drug, HC022, in 32 adults with lupus (SLE or CLE). The main goal is to check safety and side effects, not to cure the disease. Participants will receive multiple doses of the drug or a placebo, and researchers will also measure how the drug move…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Engineered immune cells take aim at lupus in early trial
Disease control Not yet recruitingThis early-stage trial tests a one-time infusion of specially designed immune cells (CAR T cells) in 20 people with severe lupus that hasn't responded to standard treatments. The cells target two proteins (BCMA and CD19) to help reset the immune system and reduce disease activity…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE1, PHASE2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Mediterranean diet may tame lupus in kids
Disease control Not yet recruitingThis study tests whether a Mediterranean diet can improve gut health, reduce disease activity, and boost nutrition in children with lupus. Sixty children with lupus and their healthy family members will take part. For 12 weeks, the children with lupus will receive nutrition couns…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: NA • Sponsor: TC Erciyes University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New cell therapy trial offers hope for kids with tough autoimmune diseases
Disease control Not yet recruitingThis early-stage study will test a new cell therapy called YTS109 in 12 children aged 5 to 17 with severe autoimmune diseases like lupus and scleroderma that haven't responded to other treatments. The goal is to see if the therapy is safe and can help control the disease. Childre…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Hidden lupus: study aims to uncover why some patients are misdiagnosed
Knowledge-focused Not yet recruitingThis study looks at 400 people with lupus to compare those with typical symptoms versus those with unusual or 'atypical' symptoms. Atypical lupus can be harder to diagnose and may lead to worse health outcomes. Researchers will track disease activity and organ damage over time to…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC